1 / 24

Western SOS Organic Chemistry 2223b

Western SOS Organic Chemistry 2223b. Moti Gulersen HBMSc mgulerse@uwo.ca Physiology Pharmacology/Toxicology. Metabolism of Glucose. Key Reactions…page 76. adding a phosphate to glucose Add: sugar = nucleophile, ATP = electrophile Remove: sugar = electrophile, ADP = nucleophile

carlos-ruiz
Download Presentation

Western SOS Organic Chemistry 2223b

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Western SOSOrganic Chemistry 2223b Moti Gulersen HBMSc mgulerse@uwo.ca Physiology Pharmacology/Toxicology

  2. Metabolism of Glucose

  3. Key Reactions…page 76 • adding a phosphate to glucose • Add: sugar = nucleophile, ATP = electrophile • Remove: sugar = electrophile, ADP = nucleophile • isomerization • base takes alpha-hydrogen • aldolase (retro-aldol; iminium ion in animals) • NADH = hydride donor (nucleophilic addition) • mutase – transferring functional groups • enolase = E2

  4. More info • Pyruvate dehydrogenase complex • why TPP? …decarboxylation • attack lipoic acid, removal of TPP • conversion to acetyl CoA via NAS • reduced lipoic acid oxidized back via FAD (remember NAD+?)

  5. More info • Aminotransferase reactions • PLP = amino-group carrier (usually bound to enzyme) • alpha-amino acid replaces enzyme, imine position switches • return hydrogen to “PLP” • hydrolysis of imine to make transfer • Practice questions • 49, 50, 51 • remember what nucleophile, electrophile

  6. Lipids:The Big Kahuna

  7. Start • Hydrolysis of ester in glycerol • acid = catalysis, base = completion • Cis vs. trans fatty acids • In lab prep of FA • CLAISEN CONDENSATION = aldol with esters • 1. attack of enolate to form beta-ketoester • 2. reduce/dehydrate/reduce • Can we do this in the body? Yes, but… • need modified claisen-type • diffusion problem • need bioreagents to reduce/dehydrate/reduce

  8. Biosynthesis • Modified claisen condensation • Thioesters instead of oxygen ester (why?) • Carbanion equivalents (malonyl thioester) • Concomitant attack (sound familiar? chymotrypsin) • Where does malonyl thioester come from? Biotin-dependant carboxylation • ATP phosphorylates HCO3- to form carboxyphosphate • Biotin attacks carboxyphosphate to make carboxybiotin • Thioester attacks carboxybiotin • Diffusion problem • Use FAS (ACP = acyl carrier protein, flexible) • Know what is E, Nu and malonyl always attached to ACP

  9. Biosynthesis • Reduction/dehydration agents • Reduction = NADPH, michael addition • Dehydration = base from enzyme • What do you need to elongate an existing fatty acid chain by 2 carbons? • Catabolism of Triglycerides • Hydrolysis via lipase • Phosphorylation and oxidation of Glycerol • Beta-oxidation of FA’s • Reverse of fatty acid synthesis BUT FAD used instead of NADPH to make C=C • Cysteine residue to “cleave”

  10. More info • Soap = metal salts of fatty acids (forms micelle) • Detergents = sulfonates or monoesters of sulfate, why? • Alkyl benzyl sulfonates • Formation of alkyl tail (electrophilic addition) • Attachment of tail to benzene (EAS) • Sulfonation at para position (EAS), why? • ***EDG vs. EWG***

  11. More info • Additives (phophate chelates) • Waxes = monoesters of long-chain alcohols and fatty acids • Phospholipids = glycerol esterified to two fatty acids and phosphate (various heads) • Prostaglandins = oxidation of arachadonic acid via cox-2 • inflammation • Leukotrienes = oxidation of arachadonic acid via 5-lipoxygenase • release in response to allergens • know inhibitors

  12. Terpenes • Head-to-tail linkage until 30 and 40 carbons • Count carbons and see if divisible by 5, every terpene has tertiary carbon • Biosynthesis • DMA-OPP (electrophile) vs. IPP-OPP (nucleophile) • makes geranyl-OPP  other monoterpenes derived or can elongate up until C20

  13. Origin of DMA-OPP and IPP-OPP • Aldol reaction between acetoacetyl thioester and acetyl thioester • Once that is completed, need to: • Lose carbon • Reduce tail and phosphorylate • OH on neck needs removal • Double bond between neck and head • 1. H2O/enzyme • 2. reduce twice using NADH to form mevalonic acid • 3. 3 ATP • 4. decarboxylation • Equals IPP-OPP, what about DMA-OPP? (isomerization)

  14. More info • Steroids = three 6-membered rings and one five-membered ring • Biosynthesis of Lanosterol • Oxidation of squalene sets of cascade • Hydride shift • Fat-soluble vitamins • Vitamin A (retinol)  light absorption • Vitamin E, K, D

  15. Practice Problems • 4, 7, 9, 10*, 11, 17, 23, 25, 26, 30, 35, 38, 45

  16. Nucleic Acids

  17. The good… • Purine (N9) vs. Pyrimidines (N1), tautomerism • Nucleosides vs. Nucleotides • Major groove vs. Minor groove • PCR • melt, anneal, elongate (add at 3’ OH) = 2x • Chain termination • adding labelled ddNTP without 3’ OH • radioactive ddNTPs vs. fluorescent ddNTPs • be careful with 3’5’, 5’3 • Pyrosequencing

  18. The tough…page 33 • Chemical synthesis of nucleic acids • 5’ OH protecting group = DMT • 3’ OH protecting group = polymer (remember?) • 1. coupling reaction • acid catalyzed (tetrazole) • 5’ OH = nucleophile • Phosphoramidite = electrophile • 2. Iodine (make P better electrophile, add H2O) • 3. TCA • remove CN (E2) and polymer using NH4OH

  19. Some more info • UV damage (C > B > A) • Carcinogens (benzene, PAH’s oxidized to epoxide then bind DNA) • Practice problems • 10, 11, 13, 14, 15 • know mechanisms, sequencing techniques (differences)

  20. Pharmaceutical Drugs

  21. Development • Find NME • Nautral, SARS, SGDD, HTS • Patent • Preclinical trials (ADMET + in vitro) • IND for FDA approval • Clinical trials (Phase I, II, III) • I = healthy, II = sick; short-term , III = doctor’s office; long-term • NDA for FDA approval • Marketing, post surveillance (Phase IV)

  22. Sulfanilamide • Prodrug • Inhibition of biosynthesis • pteridine derivative (activate first) to PABA = SN2 • Glutamic acid to carboxylate (activate first) = nucleophilic acyl substitution • Where does Sulfa come in? • Sulfa = PABA • Importance of pKa • to be or not to be (ionized)? Optimal = 6

  23. Some more info • Using light and chromophores for tissue destruction • PUVA (psoralens excite and cross-link) vs. PDT (photosensitizers excite and reaction with triplet O2 to form singlet) • Advantages/disadvantages of photofrin • Practice problems • 3, 6, 9, 14, 15

  24. Practice Exam Questions

More Related